Eisai Company, Ltd. to Team Up With Sanofi-Aventis (France) On Flu Vaccine

(Reuters) - Japanese drug maker Eisai (4523.T), will tie up with France's Sanofi-Aventis (SASY.PA) to jointly develop and market a new influenza vaccine, the Nikkei business daily reported. Sales will begin in 2014, marking the first time a Japanese company will market a flu vaccine globally, the Nikkei said.

Back to news